Related Experiment Videos

Polychemotherapy in overseventy breast cancer patients

Maurizio Marangolo¹, Ugo De Giorgi

¹Dipartimento di Oncologia ed Ematologia-Azienda USL, Ravenna.

|May 7, 2002

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Risk of myelodysplastic syndrome and acute myeloid leukemia related to PARP inhibitor maintenance line in real-world ovarian cancer patients.

The oncologist·2025

Nivolumab plus cabozantinib in metastatic renal cell carcinoma: real-world evidence from the international ARON-1 study.

Frontiers in oncology·2025

Activity of Platinum Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer and DNA Damage Repair Gene Alterations.

JCO precision oncology·2025

Talazoparib plus enzalutamide in men with HRR-deficient metastatic castration-resistant prostate cancer: final overall survival results from the randomised, placebo-controlled, phase 3 TALAPRO-2 trial.

Lancet (London, England)·2025

Talazoparib plus enzalutamide in men with metastatic castration-resistant prostate cancer: final overall survival results from the randomised, placebo-controlled, phase 3 TALAPRO-2 trial.

Lancet (London, England)·2025

Breastfeeding after breast cancer in young BRCA carriers.

Journal of the National Cancer Institute·2025

See all related articles